Effective March 16,2020, PathGroup will discontinue HLA-B27 DNA Typing (Test Code: HLABP) and transition to the clinically equivalent HLA-B27 DNA Typing test (Test Code: HB27D).
Click here for more information.
Effective March 16,2020, PathGroup will discontinue HLA-B27 DNA Typing (Test Code: HLABP) and transition to the clinically equivalent HLA-B27 DNA Typing test (Test Code: HB27D).
Click here for more information.